Company news
LB Pharmaceuticals Inc news in 2025
LB Pharmaceuticals Inc's news releases, calls and decks from 2025, newest first.
LB Pharmaceuticals Added to the Russell 2000 and Russell 3000 Indices
December 10, 2025
LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
December 9, 2025
LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference
November 24, 2025
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
November 12, 2025
LB Pharmaceuticals Announces Presentation at the Stifel 2025 Healthcare Conference
November 6, 2025
LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates
November 6, 2025
LB Pharmaceuticals Appoints James Rawls, Pharm.D., as Senior Vice President of Regulatory Affairs
October 14, 2025
LB Pharmaceuticals to Present Three Posters at 38th ECNP Congress Highlighting Clinical Activity and Safety Profile of LB-102 in Schizophrenia, Including Positive Effects on Cognition and Negative Symptoms
October 6, 2025
LB Pharmaceuticals Strengthens Board of Directors with Appointments of William Kane and Rekha Hemrajani
September 25, 2025
LB Pharmaceuticals Announces Pricing of its Upsized Initial Public Offering
September 10, 2025